Introduction
============

The trace element selenium (Se) was discovered in 1817 by the Swedish chemist Berzelius. Two hundred years later, Se is well-known as an essential mineral of pivotal importance for the human health. It is established that Se displays antioxidant activity, antiinflammatory chemopreventive, and antiviral characteristics ([@b46-btt-2-265]). Its effect on human health is due to its presence within some proteins ([@b35-btt-2-265]). Unlike other metal elements that interact with proteins in form of cofactors, Se becomes cotranslationally incorporated into polypeptide chain as part of the amino acid selenocysteine (Sec), also known as the 21th aminoacid ([@b27-btt-2-265]). The group of proteins that contain Sec as an integral part of their polypeptide chain are defined as selenoproteins. Between the domains, 25 selenoprotein families have been identified in humans ([@b15-btt-2-265]). The human selenoproteome is composed of 17 selenoprotein families, some with multiple genes having similar functions. These comprise glutathione peroxidase (GPx) (five genes), thioredoxin reductase (TrxR) (three genes), and iodothyronine deiodinases (DIO) (three genes), which have been functionally characterized as having oxidoreductase functions ([@b35-btt-2-265]). The entry point of Se in animals is via plants, which absorb the element in its organic form from the soil, where its content varies between different areas. In plants, Se becomes converted to organic forms such as methylated low-molecular-weight Se compounds and the amino acid selenomethionine (SeMet) and Sec ([@b60-btt-2-265]). Importantly, Se compounds have the capacity to redox cycle and are metabolized to more reduced states, which are thought to account for Se compounds being effective antioxidants. In fact, Sec is part of the catalytic group within selenoenzymes and is directly involved in redox reactions ([@b62-btt-2-265]). The effects of Se on the organism are concentration-dependent, ranging from an antioxidant activity in the nanomolar--micromolar range to potentially prooxidant at concentrations above what is required for maximal selenoprotein synthesis. At even higher concentrations, Se compounds may accumulate and redox cycle with intracellular thiols, inducing oxidative stress and cellular damage ([@b58-btt-2-265]). Se is essential for life, and there is no doubt that adequate amounts of this element are required for optimal human health. Many of its physiologic roles may be ascribable to its presence within selenoproteins. For example, one of the most important cellular processes, DNA synthesis, depends on the presence of Se within the catalytic site of TrxR ([@b5-btt-2-265]). Moderate Se deficiency has been associated to many conditions, such as increased risk of cancer and infections, male infertility, increased thyreocytes damage, and serious neurological diseases, including Alzheimer's and Parkinson's ([@b46-btt-2-265]). However, for some of these conditions, the evidence is rather scant, conflicting data have been published, and need further confirmations. On the contrary, a pathological condition that is certainly associated with Se deficiency is Keshan disease, a potentially fatal form of cardiomyopathy; this disease is prevalent in children and is endemic in some areas of China characterized by extremely low levels of Se in the soil ([@b37-btt-2-265]). It is supposed that infection by Coxsackie B virus may trigger the onset of this disease. Notably, the condition is prevented or completely reversed by Se supplementation ([@b61-btt-2-265]). Another disease due to a combined deficiency of Se and iodine is myxedematous cretinism which is characterized by mental and growth retardation ([@b57-btt-2-265]). It is ascertained that Se deficiency causes a reduction in GPx and DIO enzymes activity, accumulation of hydrogen peroxide (H~2~O~2~) causing damage to the thyroid gland, and impaired thyroid hormone metabolism. Se supplementation in this condition must be administered after iodide levels have been restored, as Se increases the activity of DIO, leading to a further loss of iodide from the damaged thyroid ([@b63-btt-2-265]).

In the United States, where dietary intakes are higher than in many other countries, the current recommendation is 55 μg/day. In the United Kingdom, however, Se intake is considerably lower, and the recommended dose is 75 μg/day for men and 60 μg/day for women ([@b56-btt-2-265]). These recommendations were based on the plasma GPx optimal enzyme activity, however, a recent study indicates that higher Se intake is required to obtain full expression of selenoprotein P (SelP) ([@b61-btt-2-265]). Then, it is suggested that SelP may be a better indicator of Se nutritional status than GPx, and that the recommended dietary intake may need to be revised.

Even if a large body of studies has made available a vast information about Se, the precise molecular mechanisms behind its effects in physiologic and pathologic conditions remain unknown.

The best known and most important human selenoproteins
======================================================

The most common form of Se in human proteins is Sec, which becomes cotranslationally incorporated within the growing polypeptide chain. However, selenium-containing proteins exists also in other forms, such as proteins that nonspecifically incorporate Se during translation, and selenium-binding proteins that bind Se as a cofactor. Only a few of the 25 identified mammalian selenoproteins have so far been functionally characterized. Most of these selenoproteins exhibit enzymatic redox function via Sec, which confers their catalytic and antioxidant activities ([@b15-btt-2-265]).

Thioredoxin reductase
---------------------

Thioredoxin reductase (TrxR) and NADPH constitute the thioredoxin system, a major cellular redox system present in all living organisms ([@b5-btt-2-265]). Three mammalian TrxR selenoenzymes have been identified: the cytosolic enzyme (TrxR1), the mitochondrial enzyme (TrxR2), and a testis-specific enzyme thioredoxin-gluthatione reductase (TrxR3) ([@b55-btt-2-265], [@b54-btt-2-265]). The Trx system plays a pivotal role in embryo development. Knockout mouse model for Trx gene (Txn) are not vital and homozygous mutants for TrxR1 die shortly after implantation as a result of failure to proliferate, suggesting that TrxR is essential for early differentiation and morphogenesis ([@b38-btt-2-265]; [@b30-btt-2-265]). The similar Txn knockout and TrxR1 homozygous mutants phenotypes are mostly likely explained by impaired DNA synthesis due to accumulation of oxidized, nonfunctional ribonucleotide reductase. These results confirm that the TrxR system is absolutely required for development, and probably cell proliferation in vivo, and also emphasize the importance of the Sec residue for catalytic activity. As observed for the TrxR1, complete removal of mitochondrial TrxR2 causes embryonic death and homozygous mutant embryos show decreased hematopoiesis, increased apoptosis in the liver, and cardiac defects ([@b43-btt-2-265]; [@b17-btt-2-265]).

Glutathione peroxidases (GPx)
-----------------------------

Glutathione peroxidases (GPx) was the first mammalian protein shown to incorporate Se in the form of Sec into catalytic site and was supposed to be associated with the anti-oxidant activity of Se. GPxs are recognized for catalyzing the reduction of hydrogen peroxide and organic hydroperoxides, thus protecting cells from oxidative damage. The importance of glutathione peroxidases and their potentially beneficial role in critically ill patients concerns the mechanism of detoxification of peroxides to their respective alcohols at the expense of glutathione. It seems that all of the glutathione peroxidase isoforms share the same catalytic mechanism, with a highly conserved sequence of selenocysteine, tryptophan and glutamine ([@b7-btt-2-265]; [@b14-btt-2-265]). The role of plasma GPx as an antioxidant enzyme is not fully understood. Although its preferred substrate, glutathione, usually has a low plasma concentration, increased cellular oxidative stress can export oxidized glutathione to the plasma compartment, where a combination of glutathione reductase and GPx can restore redox balance and either return reduced glutathione to the cell, or use it as a substrate for plasma GPx. Thus, Se can act as antioxidant when incorporated as selenoenzymes in the extracellualr space, the cell cytosol, in association with cell membranes, having the potential role to influence the immune processes ([@b6-btt-2-265]). Localization and main function of the seven GPx isoenzymes are resumed in [Table 1](#t1-btt-2-265){ref-type="table"}.

Iodothyronine deiodinases
-------------------------

Three differentially distributed Sec-containing oxidoreductases (DIO1, DIO2, DIO3) constitute the family of iodothyronine deiodinases (DIO). They catalyze the activation (DIO1 and DIO2) and inactivation (DIO3) of the thyroid hormones thyroxine (T4), 3,5,3'-triodothyronine (T3), and reverse-3,5,3'-triiodothyronine (rT3) by removing distinct iodine moieties, as indicated in [Figure 1](#f1-btt-2-265){ref-type="fig"} ([@b10-btt-2-265]). Among their actions, thyroid hormones contribute to regulate the function of heart, metabolism, growth, are pivotal for the development of the fetal brain, and display multiple interactions with other hormonal systems. DIOs exhibit different localizations and function in human tissues ([@b49-btt-2-265]). DIO1 is expressed mostly in the liver, kidney, thyroid, and pituitary; DIO2 in the thyroid, central nervous system, pituitary, and skeletal muscle; DIO3 is most prominently expressed in the pregnant uterus, placenta, embryonic liver, embryonic and neonatal brain, and neonatal skin. The three DIOs exert different actions as DIO1 plays a role in T3 production in the thyroid gland and controls the circulating T3 levels, whereas DIO2 and DIO3 are proposed to function in the local deiodination processes. Recent evidence indicates that DIO2 represents a major source of circulating T3 in euthyroid humans, whereas DIO1 contributes more substantially at high, thyrotoxic T4 levels, as seen in hyperthyroid patients. The presence of Sec appears to be absolutely required for DIO catalytic activity and thus it is not surprising that Se levels have a direct regulatory effect on the expression of DIOs ([@b9-btt-2-265]; [@b34-btt-2-265]). Among various selenoproteins, DIOs rank high in the hierarchy of Se supply during Se deficiency, DIO1 expression being maintained or slightly increased in the thyroid gland. In the brain and placenta, DIO1 and DIO3 expression is maintained during Se restriction, whereas DIO1 expression decreases in other tissues. The mechanisms of DIOs regulation by Se availability is not fully understood, nevertheless, it appears to be tissue- or organ-specific. Additional regulators of DIOs expression are T3 and thyrotropin (TSH) (which act in a feedback loop), and cyclic adenosine monophosphate (cAMP) ([@b33-btt-2-265]). Experimental models with knockout transgenic mouse, provided evidence of the crucial roles exerted by DIOs. In particular, knockout mice for DIO1 display abnormal concentrations of thyroid hormones and their metabolities, suggesting a role in preserving iodine store within the organism; DIO2 deficient mice have alterations in auditory function, thermogenesis, and brain development; DIO3 knockout models exhibit reduced viability, growth retardation, impaired fertility, reduced T3 and increased T4 levels ([@b49-btt-2-265]). There are not well documented diseases derived from primary DIOs deficiency in humans. However, in 2005, mutations of Sec binding protein 2 have been identified. The authors reported an inherited selenocysteine defect, caused by a homozygous misense mutation of SBP2, which is an indispensable protein for selenoprotein synthesis, resulting in abnormalities in the deiodinases and defective thyroid metabolism ([@b21-btt-2-265]). Several diseases with disturbed thyroid hormone metabolism and expression of DIOs are known. In Graves' hyperthyroidism the increased levels of T3 are known to induce DIO1 expression at the transcriptional level, which further contributes to the progression of the disease; on the other hand the use of propylthiouracil (PTU) inhibits DIO1 by binding to Sec residue, which represents a benefit in the treatment of hyperthyroidism ([@b11-btt-2-265]; [@b36-btt-2-265]). In hypothyroidism, decreased DIO1 levels with a concomitant increased DIO2 activity may be observed, potentially to serve as a rescue mechanism to provide local levels of T3 ([@b11-btt-2-265]). Combined Se and iodine deficiency leads to the condition of myxedematous cretinism. Reduced DIOs and GPx activity are both supposed to play a central role for the development of this disease. The decreased GPx activity increase oxidative damage in the thyroid, while the reduced DIO concentration profoundly alters thyroid hormone metabolism ([@b34-btt-2-265]). The involvement of Se and selenoproteins in autoimmune thyroid diseases are discussed in a separate paragraph.

Other selenoproteins
--------------------

Several others selenoproteins have been identified, and their localizations and functions have been quite clearly defined. They are involved in multiple processes that concern transport and delivery of Se, apoptosis, proliferation and cancer, muscle cells function, inflammation, and oxidation (see [Table 2](#t2-btt-2-265){ref-type="table"}). Furthermore, there are some others selenoproteins that have not been characterized (SelH, SelO, SelT, and SelV), and whose functions are thought to be related to redox processes ([@b15-btt-2-265]).

Selenium and thyroid metabolism
===============================

The importance of Se for the thyroid function has been increasingly recognized and multiple laboratory experiments, clinical trials, and epidemiologic data have progressively revealed the relationships between Se, iodine, and thyroid hormones metabolism. Of interest, for example, is the condition of iodine deficiency. This situation, which is associated with high TSH values, produce increased levels of H~2~O~2~ ([@b48-btt-2-265]). The cytotoxic action on thyroid cells depends on both the formation of free radicals and the defence ability of antioxidative enzymes, the latter being impaired in a state of Se deficiency and altered selenoproteins activity ([@b23-btt-2-265]). In order to accept electrons derived from oxidative reactions, the thyroid cells physiologically generate a large amount of H~2~O~2~ at the cell surface. The thyroid is thus a source of H~2~O~2~, a necessary substrate for thyroperoxidase (TPO) activity. The generation of H~2~O~2~ is the rate-limiting step in the thyroid hormone synthesis and is regulated by TSH action on an interacting second-messenger system ([@b32-btt-2-265]). The production of H~2~O~2~ leads to the iodination of tyrosine residues and the coupling of iodinated tyrosines to thyroglobulin (Tg). It is known that the Tg iodination *in vivo* takes place on the external surface of the apical plasma membrane, where TPO is integrated and H~2~O~2~ is generated ([@b12-btt-2-265]). H~2~O~2~ may easily cross the apical membrane to the luminal site where it reacts with TPO for the iodination of Tg. Then, when H~2~O~2~ is available, iodination may be catalyzed by TPO and controlled by GPx, which degrades H~2~O~2~. Excess H~2~O~2~ may diffuse into the cell, where it will promptly be attacked by GPx, TRx, and catalase, which is present in the peroxisomes ([@b18-btt-2-265]). Increased GPx activity reduces H~2~O~2~ availability, whereas in conditions of Se deficiency decreased GPx activity results in higher generation of H~2~O~2~ and increased TPO activity. Therefore, the expected activity of the GPx system plays a pivotal function in the iodination process, while, the intrathyroidal concentration of Se is important for GPx activity. The GPx and catalase antioxidant systems are protected by the antioxidant protein thiol-specific anti-oxidant (TSA), which modulates H~2~O~2~-mediated responses. TSA is TSH-dependent regulated, although the effect of TSH on TSA gene expression at the transcriptional level remains unclear ([@b31-btt-2-265]).

Selenium and thyroid autoimmunity
=================================

Some interventional studies have tested the hypothesis that Se administration may have a beneficial effect on autoimmune thyroiditis (AIT). It has recently been reported that in patients with AIT from an area in South Germany with borderline Se intake, 200 μg 3-month Se supplementation, in the form of selenite, significantly reduced anti-TPOAb concentration and improved ultrasound echomorphology ([@b25-btt-2-265]). In a 6-month follow-up crossover study, the anti-TPO concentrations continued to decrease significantly in the group that received Se, whereas the anti-TPOAb titers significantly increased in the group that stopped taking Se ([@b26-btt-2-265]). These findings are supported by another study conducted in patients with AIT in a non-Se-deficient area in Greece, in which anti-TPOAb concentrations also significantly decreased with a combined treatment over 6 months of 200 μg of selenomethionine and LT4 ([@b22-btt-2-265]). Anti-TPOAb reduction was prominent in the first 3 months of treatment, which may be the result of elevated intrathyroidal Se levels achieved during the study with consequent enhancement of the scavenging activity of both the GPx and TRx systems. In this respect, supplemented Se protected against goiter and thyroid tissue damage in a study from France that included 792 men and 1108 women from the SU.VIMAX study ([@b20-btt-2-265]). The authors also found a relationship to thyroid echostructure and concluded that Se may protect against autoimmune thyroid disease. Another recent study from Greece, evaluated the effects of Se supplementation (200 μg/day) in patients suffering from AIT. After 6 months of treatment a 9.9% reduction of TPOAb titers was observed; afterwards, while in one group the Se supplementation was continued, and a further decrement of TPOAb was observed, in the other group which stopped supplementation, a 4.8% increase took place ([@b39-btt-2-265]). It has also been suggested that Se administration may have a protective role in pregnant women with AIT who are at a higher risk of miscarriage, as women with pregnancy loss had significantly lower Se hair content than controls ([@b4-btt-2-265]; [@b45-btt-2-265]). A particularly interesting patients in the field of AIT, is represented by pregnant women. These patients are characterized by an increased risk of miscarriage, preterm delivery, and development of thyroid dysfunction after delivery ([@b41-btt-2-265]). One study, involving 2143 euthyroid pregnant women (7.9% of them with TPOAb), evaluated the effects of 200 μg of selenomethionine supplementation during and after pregnancy. Results showed that, in women with autoimmune chronic thyroiditis, post-partum thyroid dysfunction and permanent hypothyroidism were lower in the treated group in respect to the untreated group (28.6 *vs*. 48.6%, *P* \< 0.01; and 11.7 *vs*. 20.3%, *P* \< 0.01, respectively) ([@b42-btt-2-265]) ([Figure 2](#f2-btt-2-265){ref-type="fig"}). The same study demonstrated that the Se supplemented women displayed lower TPOAb titers during the postpartum period and better thyroid ultrasound patterns when compared with the untreated ones. Finally, [@b40-btt-2-265] reported in a paper published in 2005 few cases of patients with autoimmune hypothyroidism who benefited from a daily Se supplementation. The cited patients, having serum Se concentrations below the lower limit, had an extraordinary recovery of thyroid function after Se treatment, with a condition of restored euthyroidism and an ameliorated ultrasound echogenicity pattern ([@b40-btt-2-265]).

Despite their different phenotypes, Hashimoto's thyroiditis and Graves' disease (GD), share the production of organ-specific antibodies, and a common genetic background ([@b19-btt-2-265]; [@b53-btt-2-265]; [@b16-btt-2-265]). GD is characterized by a condition of increased oxidative stress, not only in the acute phase of the disease, but also in the state of euthyroidism, induced by anti-thyroid medications ([@b3-btt-2-265]). In fact, several studies outlined the association of GD with impaired antioxidant activity. Urinary malondialdehyde levels, a marker of oxidative stress, is higher in hyperthyroid patients compared to euthyroid controls ([@b28-btt-2-265]). In patients suffering from GD, the use of antithyroid drugs, either methimazole or propylthouracil, have been proven to be effective in lowering oxidant generation and improving the imbalance of the antioxidant/oxidant status ([@b47-btt-2-265]; [@b1-btt-2-265]). A recent study by [@b59-btt-2-265] compared serum Se levels in patients with remission and relapse of GD. The authors found that highest serum Se levels (\>120 microg/l) were seen in the remission group, indicating a positive effect of Se levels on the outcome of GD. In addition, the authors showed that TSH-receptor antibodies levels and serum Se values were positively correlated in the relapse group, whereas a negative correlation of both parameters were seen in the remission group, supporting the idea of a positive effect of Se on thyroidal autoimmune process ([@b59-btt-2-265]). One study from Croatia, evaluated the effects of supplementation with a fixed combination of antioxidants (vitamins C and E, beta-carotene and selenium) on superoxide dismutase activity, copper and zinc concentrations, and total antioxidant status in erythrocytes derived from a group of patients with GD treated with methimazole, with respect to the rate of achieving euthyroidism ([@b8-btt-2-265]). Results showed that patients receiving antioxidant supplementation along with methimazole therapy achieved euthyroidism at a faster rate than those treated with methimazole alone. The activity of superoxide dismutase similarly decreased in both groups, while the total antioxidant status was mostly improved in the supplemented group. Taking together, the abovementioned studies' results, may lead to think that Se supplementation may exert a beneficial effect on the course of GD.

Conclusion
==========

Se is a mineral of pivotal importance for human health. It is an integral part of selenoproteins, many of which are involved in redox processes and are effective as antioxidants. The most frequent disease involving the thyroid gland is the autoimmune chronic thyroiditis, an inflammatory process which progressively destroy the gland. Several studies have examined the potential benefits of Se in this disease to assess if its supplementation may be effective in increasing the antioxidant defences. These studies have by consent demonstrated that Se supplementation, probably maximizing the Se-dependent enzymes activity, is able to reduce the inflammatory state, exerting a decline of TPOAb titers and an amelioration of the ultrasound pattern. Furthermore, there are some preliminary data which indicate a possible role of Se supplementation in ameliorating the course of GD, even if specifically and well-designed randomized controlled trials are necessary to address this issue.

However, several points have to be still clarified. Firstly, we have not fully understood functions and actions of the already identified selenoproteins; then, the first question is whether the effect of Se on thyroid autoimmunity depends on the maximization of GPx activity alone or also of other selenoproteins. Secondly, it has still to be defined the exact amount of Se to be given to maximize the enzymatic antioxidant activity. Thirdly, a cost/benefit evaluation is mandatory; in fact, the final result of autoimmune chronic thyroiditis is represented by hypothyroidism; Se supplementation should delay the time of Levothyroxine initiation, but obliges in any case the patient to take a tablet a day, and even when hypothyroidism develops, substitutive treatment with Levo-thyroxine has no side effects and it is a very cheap drug. One viable application of Se, may be its supplementation during pregnancy (possibly in conjunction with iodine supplementation). In fact, by now, screening for thyroid function during pregnancy is not warranted ([@b2-btt-2-265]). Considering that up to \~10% of pregnant women are positive for TPOAb, and that about 8% of all pregnant women develop postpartum thyroiditis, it is plausible a positive effect exerted by Se in this particular kind of patients ([@b44-btt-2-265]; [@b50-btt-2-265]). Finally, it has to be reminded that Se have had a putative role in preventing atherosclerosis and carcinogenesis, and a possible action in improving glucose metabolism. All these hypothesis have been proven to be wrong, and in addition, a recently published study even suspected Se to be responsible for increased risk of developing diabetes ([@b29-btt-2-265]; [@b24-btt-2-265]; [@b13-btt-2-265]; [@b52-btt-2-265]).
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###### 

Localization and function of glutathione peroxidase ([@b51-btt-2-265])

  Glutathione peroxidase isoenzyme   Localization                                                                                                                                               Function
  ---------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **GPx 1**                          Liver, erytrocytes                                                                                                                                         Important in severe oxidative stress. Role in viral infectious processes
  **GPx 2**                          Liver, gastrointestinal tract                                                                                                                              First line of defence against ingested organic hydroperoxides. Involvement in apoptosis, cellular proliferation
  **GPx 3**                          Plasma, intestine, breast milk, adrenal gland, pulmonary lavage fluid, renal proximal tubules                                                              Thought to have largely regulatory functions associated with oxidative stress and malignancy. Expression induced by hypoxia
  **GPx 4**                          Distributed in cytoplasm, nucleus and mitochondria. Expressed in testis, lung, heart, cerebellum. Essential structural component of the sperm's midpiece   Antioxidant involved in protection of biomembranes. Reduces phospholipids hydroperoxides in cellular membranes. Involved in redox signalling and regulatory processes (apoptosis, inhibition of lipoxygenases). Required for sperm fertilization. Lack of GPx 4 is lethal at an early embyogenic stage
  **GPx 5**                          Epididymis                                                                                                                                                 Potentially serves a "backup" function for selenocysteine containing GPx isoforms in sperm. Can be secreted or membrane-bound
  **GPx 6**                          Bowman's gland, olfactory epithelium, embryonic tissues                                                                                                    Olfaction. Putative odorant metabolizing enzyme
  **GPx 7**                          Breast tissues                                                                                                                                             Breast cancer defense against oxidative stress

**Abbreviation:** GPx, glutathione peroxidases.

###### 

Localizations and functions of selenoproteins other than GPx, DIO, and TrxR

  Selenoproteins                                 Localization                                            Function
  ---------------------------------------------- ------------------------------------------------------- ----------------------------------------------------------------------------------
  **Selenoprotein P**                            Secreted to plasma by liver                             Contains 50% of plasma Se
  Expressed in all tissues                       Transport and delivery of Se                            
  Heavy-metal chelator                                                                                   
  **Selenoprotein 15**                           Brain, lung, testis, liver, thyroid, kidney             Involved in glycoprotein folding
  Potential tumor-suppression function                                                                   
  **Selenoprotein N**                            Expressed in all tissues                                Plays a pivotal role in muscle tissues
  **Selenoprotein W**                            Muscles, heart, intestine, prostate, esophagus, skin    Antioxidant function
  Putative functional role in muscle and brain                                                           
  **Selenophosphate synthetase 2**               Expressed in all tissues                                Essential component of the Sec biosynthesis machinery
  **Selenoprotein R**                            Expressed in all tissues                                Repairing of oxidative damaged proteins
  **Selenoprotein M**                            Heart, lung, kidney, uterus, placenta, thyroid, brain   Potential role in the brain (low levels are associated with Alzheimer's disease)
  **Selenoprotein S**                            Expressed in all tissues                                Link between type 2 diabetes, inflammation, and cardiovascular disease
  **Selenoprotein K**                            Heart, muscle, pancreas, liver, placenta                Antioxidant function in the heart

**Abbreviation:** Se, selenium.
